Biomarin Pharmaceutical (BMRN) Interest Coverage Ratio (2009 - 2026)
Biomarin Pharmaceutical (BMRN) posted Interest Coverage Ratio of 7.45 for Q1 2026, up 222.32% on a QoQ basis from 6.09 in Q4 2025, and down 90.48% year-over-year from 78.2 in Q1 2025.
Biomarin Pharmaceutical (BMRN) Interest Coverage Ratio (2009 - 2026) Analysis & Trends
Biomarin Pharmaceutical's Interest Coverage Ratio history runs 18 years deep, the most recent figure standing at 7.45 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 90.48% year-over-year to 7.45 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 18.11 (down 63.05% YoY) and the FY2025 annual result came in at 2.25, down 41.23% from the prior year.
- Interest Coverage Ratio was 7.45 for Q1 2026 at Biomarin Pharmaceutical, up from 6.09 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 78.2 in Q1 2025 and bottomed at 18.1 in Q3 2025.
- A 5-year average of 22.16 and a median of 16.85 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio surged 4070.59% — and 2025, when it tumbled 149.74%.
- Biomarin Pharmaceutical's Interest Coverage Ratio stood at 6.34 in 2022, then tumbled by 79.97% to 1.27 in 2023, then jumped by 4070.59% to 53.01 in 2024, then sank by 111.49% to 6.09 in 2025, then soared by 222.32% to 7.45 in 2026.
- Business Quant data shows BMRN's Interest Coverage Ratio at 7.45 in Q1 2026, 6.09 in Q4 2025, and 18.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Biomarin Pharmaceutical | 11.33 Bn | 9.11 Bn | 571.21 Mn | 7.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.45 |
| Dec 31, 2025 | -6.09 |
| Sep 30, 2025 | -18.10 |
| Jun 30, 2025 | 72.14 |
| Mar 31, 2025 | 78.20 |
| Dec 31, 2024 | 53.01 |
| Sep 30, 2024 | 36.40 |
| Jun 30, 2024 | 33.38 |
| Mar 31, 2024 | 24.53 |
| Dec 31, 2023 | 1.27 |
| Sep 30, 2023 | 8.08 |
| Jun 30, 2023 | 17.46 |
| Mar 31, 2023 | 16.85 |
| Dec 31, 2022 | 6.34 |
| Sep 30, 2022 | -0.52 |
| Jun 30, 2022 | 10.15 |
| Mar 31, 2022 | 36.08 |
| Dec 31, 2021 | -3.28 |
| Sep 30, 2021 | -13.75 |
| Jun 30, 2021 | 3.06 |